Imaging and Radiotherapy Options in Neuroblastoma

Course overview

UAN: 0018-0000-18-214-H04-P & T RELEASE: 12/17/2018 EXPIRE: 12/17/2021 CREDITS: 2.0 LEARNING OBJECTIVES: 1. Explain the role of nuclear medicine in the diagnosis and monitoring of neuroblastoma 2. Recognize other nuclear medicine options that can be used in evaluating, monitoring and treating neuroblastoma NOTE: An annual subscription for Purdue's nuclear pharmacy re-certification program provides access to both the continuing education component of the program and the "Radiopharmacy Portal" a reference resource for practitioners. Subscriptions to the continuing educational offerings, which have been accredited through ACPE and BPS, can be purchased for an annual fee of $195 for nuclear pharmacists and $95 for nuclear pharmacy technicians.